Utah Medical Products (NASDAQ:UTMD) was downgraded by stock analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Tuesday.

Shares of Utah Medical Products (NASDAQ UTMD) traded down $0.05 during trading on Tuesday, reaching $80.50. The company had a trading volume of 7,189 shares, compared to its average volume of 10,336. Utah Medical Products has a 52-week low of $58.50 and a 52-week high of $83.15. The stock has a market capitalization of $300.31, a P/E ratio of 22.01 and a beta of 0.78.

A number of institutional investors have recently made changes to their positions in the stock. Rice Hall James & Associates LLC lifted its position in Utah Medical Products by 1.1% during the second quarter. Rice Hall James & Associates LLC now owns 3,829 shares of the medical instruments supplier’s stock worth $277,000 after buying an additional 40 shares in the last quarter. Strs Ohio lifted its position in Utah Medical Products by 8.0% during the second quarter. Strs Ohio now owns 2,700 shares of the medical instruments supplier’s stock worth $195,000 after buying an additional 200 shares in the last quarter. Teachers Advisors LLC lifted its position in Utah Medical Products by 3.8% during the second quarter. Teachers Advisors LLC now owns 5,710 shares of the medical instruments supplier’s stock worth $413,000 after buying an additional 208 shares in the last quarter. Northern Trust Corp lifted its position in Utah Medical Products by 0.6% during the second quarter. Northern Trust Corp now owns 53,294 shares of the medical instruments supplier’s stock worth $3,858,000 after buying an additional 305 shares in the last quarter. Finally, Seizert Capital Partners LLC lifted its position in Utah Medical Products by 5.2% during the second quarter. Seizert Capital Partners LLC now owns 6,512 shares of the medical instruments supplier’s stock worth $471,000 after buying an additional 320 shares in the last quarter. Hedge funds and other institutional investors own 66.67% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Utah Medical Products (UTMD) Downgraded by BidaskClub” was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/12/12/utah-medical-products-utmd-downgraded-by-bidaskclub.html.

About Utah Medical Products

Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.